Increased PDE6D levels in ICA may enhance tumor growth by modulating intracellular cyclic nucleotide levels, influencing pathways such as MAPK/ERK and PI3K/Akt, which are often dysregulated in cancer [[57], [58], [59], [60], [61], [62]]. The gene discussed is AKT1; the disease is cancer.